Mechanism of interaction of hypoglycemic agents glimepiride and glipizide with human serum albumin

Mechanism of interaction of hypoglycemic agents glimepiride and glipizide with human serum albumin

Bibliographic Details
Main Authors:	Seedher Neelam, Kanojia Mamta
Format:	Article
Language:	English
Published:	De Gruyter 2009-03-01
Series:	Open Chemistry
Subjects:	binding fluorescence glimepiride glipizide hsa
Online Access:	https://doi.org/10.2478/s11532-008-0080-x

Similar Items

Solubility Enhancement of Antidiabetic Drugs Using a Co‐Crystallization Approach
by: Dr. Eustina Batisai
Published: (2021-12-01)

Evaluation of physicochemical properties and in-vitro release profile of glipizide-matrix patch
by: Kajal Ghosal, et al.
Published: (2010-06-01)

Formulation and evaluation of glipizide floating-bioadhesive tablets
by: Jayvadan K. Patel, et al.
Published: (2010-10-01)

Bromocriptine, a Dopamine (D2 ) Receptor Agonist, Used Alone and in Combination with Glipizide in Sub–Therapeutic Doses to Ameliorate Hyperglycaemia
by: Harish Kumar V.S., et al.
Published: (2013-09-01)

Optimization of therapy of type 2 diabetes mellitus with the oral hypoglycemic agent glimepiride
by: Tatiana Ivanovna Romantsova, et al.
Published: (2010-03-01)

Evaluation of commercial arrowroot starch/CMC film for buccal drug delivery of glipizide
by: Dhanasekaran Gayathri, et al.
Published: (2020-04-01)

Development of lipid micromatrices based sustained release tablets of glipizide: suitability of stearic acid as release retardant
by: Deepak Singh, et al.
Published: (2016-06-01)

Pharmacokinetic Herb-Drug Interactions of Glipizide with <i>Andrographis paniculata</i> (Burm. f.) and Andrographolide in Normal and Diabetic Rats by Validated HPLC Method
by: Elza Sundhani, et al.
Published: (2022-10-01)

Transdermal Glipizide Delivery System Based on Chitosan-Coated Deformable Liposomes: Development, Ex Vivo, and In Vivo Studies
by: Mohamed M. Badran, et al.
Published: (2022-04-01)

Stress degradation study of two oral antidiabetics, gliclazide and glipizide, and chemical analysis by LC and LC/MS methods
by: Gumieniczek Anna, et al.
Published: (2014-01-01)

Discordant Timing of Hypoglycemic Agent Screening Causing Delayed Diagnosis of Sulfonylurea-Induced Hypoglycemia
by: Andrew Folick, MD, PhD, et al.
Published: (2022-05-01)

Comparison of Hypoglycemic Activity of Berberis Lycium Royle Stem Bark and Glimepiride in Type 2 Diabetes
by: Hina Aslam, Adnan Jehangir, Uzma Naeem
Published: (2015-03-01)

Effect of herbal formulation on glimepiride pharmacokinetics and pharmacodynamics in nicotinamide-streptozotocin-induced diabetic rats
by: Archana K. Thikekar, et al.
Published: (2022-07-01)

A Glimepiride-Metformin Multidrug Crystal: Synthesis, Crystal Structure Analysis, and Physicochemical Properties
by: Xufei Bian, et al.
Published: (2019-10-01)

Short-Term Treatment of Metformin and Glipizide on Oxidative Stress, Lipid Profile and Renal Function in a Rat Model with Diabetes Mellitus
by: Abdel-Moneim Hafez Abdel-Moneim, et al.
Published: (2022-02-01)

Amphiphilic, lauric acid-coupled pluronic-based nano-micellar system for efficient glipizide delivery
by: Vipan Kumar, et al.
Published: (2024-05-01)

Place of sulfonylureas in the management of type 2 diabetes mellitus in South Asia: A consensus statement
by: Sanjay Kalra, et al.
Published: (2015-01-01)

Effect of Metformin Monotherapy and Combination Therapy with Glimepiride on Lipid Profile in Drug Naive Type-2 Diabetes Patients: A Prospective Observational Study
by: Anchit Pareek, et al.
Published: (2023-04-01)

Analysis of Glimepiride in Human Blood and Urine by Thin Layer Chromatography and UV Spectrophotometry
by: Mareta Mukharbekovna Ibragimova, et al.
Published: (2015-07-01)

Analysis of Glimepiride in Human Blood and Urine by Thin Layer Chromatography and UV Spectrophotometry
by: Mareta Mukharbekovna Ibragimova, et al.
Published: (2015-07-01)

Improved oral bioavailability of poorly water-soluble glimepiride by utilizing microemulsion technique
by: Li HY, et al.
Published: (2016-08-01)

Formulation and characterization of orodispersible tablet of glimepiride
by: Ahmad AB Yosef Kinani, et al.
Published: (2022-01-01)

The Physico-Chemical Properties of Glipizide: New Findings
by: Giovanna Bruni, et al.
Published: (2021-05-01)

Pharmacodynamic interaction of fenugreek, insulin and glimepiride on sero-biochemical parameters in diabetic Sprague-Dawley rats
by: C. Haritha, et al.
Published: (2015-05-01)

Influences of Glimepiride Self-Nanoemulsifying Drug Delivery System Loaded Liquisolid Tablets on the Hypoglycemic Activity and Pancreatic Histopathological Changes in Streptozotocin-Induced Hyperglycemic Rats
by: Tarek A. Ahmed, et al.
Published: (2022-11-01)

A pharmacoeconomic analysis to compare cost-effectiveness of metformin plus teneligliptin with metformin plus glimepiride in patients of type-2 diabetes mellitus
by: Tanya Tandon, et al.
Published: (2019-01-01)

Formulation self nano emulsifying drug delivery system glimepiride using oleic acid as oil phase
by: Sani Ega Priani, et al.
Published: (2017-12-01)

Interaction of glimepiride with prokinetic drugs on some of gastrointestinal functions in STZ-induced diabetic mice
by: Mohamed A. Fouad, et al.
Published: (2013-06-01)

Spectroscopic and in silico evaluation on the interactive behavior between substituted β-2,3-dihydrofuran naphthoquinones and human serum albumin
by: Otávio Augusto Chaves, et al.
Published: (2024-06-01)

Pharmacodynamic interaction of fenugreek with insulin and glimepiride in streptozotocin-induced oxidative stress in Sprague Dawley rats
by: Haritha Chiluka, et al.
Published: (2015-09-01)

Effects of Metformin &/or Glimepiride on Resistin Level and Related Biochemical Markers in Type 2 Diabetes Mellitus
by: Hadeel Delman Najim, et al.
Published: (2014-12-01)

Optimization of Potential Nanoemulgels for Boosting Transdermal Glimepiride Delivery and Upgrading Its Anti-Diabetic Activity
by: Marwa H. Abdallah, et al.
Published: (2023-06-01)

Novel microporous resin-based polymer device for sustained glipizide release: Production, characterization and pharmacokinetic study
by: Haofan Liu, et al.
Published: (2022-11-01)

Modern antihyperglycemic therapy: safety and efficacy of glimepiride
by: Lyudmila Alexandrovna Ruyatkina, et al.
Published: (2012-06-01)

Formulation design and development of matrix diffusion controlled transdermal drug delivery of glimepiride
by: Akram MR, et al.
Published: (2018-02-01)

Mechanistic analysis of Zein nanoparticles/PLGA triblock in situ forming implants for glimepiride
by: Ahmed OAA, et al.
Published: (2016-02-01)

Comparison of Vildagliptin-Metformin and Glimepiride-Metformin Treatments in Type 2 Diabetic Patients
by: Hyun Jeong Jeon, et al.
Published: (2011-10-01)

Synthesized nano particles of glimepiride via spray freezing into cryogenic liquid: characterization, antidiabetic activity, and bioavailability
by: Dalia A. Gaber, et al.
Published: (2022-12-01)

Evaluation of fixed dose combination of glimepiride and metformin in patients with type 2 diabetes. Results of Russian observational study
by: Natalya Vladislavovna Zaytseva, et al.
Published: (2015-06-01)

Short-term efficacy and safety of repaglinide versus glimepiride as augmentation of metformin in treating patients with type 2 diabetes mellitus
by: Xie J, et al.
Published: (2019-04-01)